Clinical Trials
126
Active:118
Completed:1
Trial Phases
4 Phases
Phase 1:114
Phase 2:3
Phase 3:2
+1 more phases
Drug Approvals
20
SFDA:20
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (121 trials with phase data)• Click on a phase to view related trials
Phase 1
114 (94.2%)Phase 2
3 (2.5%)Phase 3
2 (1.7%)Phase 4
2 (1.7%)No trials found
News
BridgeBio Secures $300 Million Royalty Financing to Support ATTR-CM Drug Launch
BridgeBio Pharma secured $300 million in upfront financing by selling 60% of European royalties for BEYONTTRA to HealthCare Royalty and Blue Owl Capital.